$38.00
-10.75[-22.05%]
At close: Apr 26
$38.00
0[0.00%]
After Hours: 8:29AM EDT
Belite Bio
(NASDAQ:BLTE)Belite Bio Stock (NASDAQ:BLTE), Analyst Ratings, Price Targets, Predictions
Belite Bio Inc has a consensus price target of $40.2, established from looking at the 23 latest analyst ratings. The last 3 analyst ratings were released from Benchmark, HC Wainwright & Co., and Cantor Fitzgerald on May 16, 2024, May 15, 2024, and May 15, 2024. With an average price target of $38.67 between Benchmark, HC Wainwright & Co., and Cantor Fitzgerald, there's an implied 1.75% upside for Belite Bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Benchmark
HC Wainwright & Co.
Cantor Fitzgerald
Maxim Group
SVB Leerink
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Belite Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/16/2024 | Buy Now | 50% | Benchmark | Bruce Jackson | → $57 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | → $59 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim | — | Reiterates | → Overweight | Get Alert |
| 03/22/2024 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | $59 → $59 | Maintains | Buy | Get Alert |
| 03/13/2024 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | → $59 | Reiterates | Buy → Buy | Get Alert |
| 12/27/2023 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | → $59 | Reiterates | Buy → Buy | Get Alert |
| 12/14/2023 | Buy Now | 57.89% | Maxim Group | Jason McCarthy | → $60 | Initiates | → Buy | Get Alert |
| 11/15/2023 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | → $59 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2023 | Buy Now | 50% | Benchmark | Bruce Jackson | → $57 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2023 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | $55 → $59 | Maintains | Buy | Get Alert |
| 08/10/2023 | Buy Now | 44.74% | HC Wainwright & Co. | Yi Chen | → $55 | Reiterates | Buy → Buy | Get Alert |
| 07/28/2023 | Buy Now | 13.16% | Cantor Fitzgerald | Jennifer Kim | → $43 | Initiates | → Overweight | Get Alert |
| 07/26/2023 | Buy Now | -34.21% | SVB Leerink | Marc Goodman | → $25 | Initiates | → Outperform | Get Alert |
| 07/25/2023 | Buy Now | 50% | Benchmark | Bruce Jackson | → $57 | Reiterates | Buy → Buy | Get Alert |
| 07/25/2023 | Buy Now | 44.74% | HC Wainwright & Co. | Yi Chen | → $55 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | Buy Now | 50% | Benchmark | Bruce Jackson | → $57 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | Buy Now | 44.74% | HC Wainwright & Co. | Yi Chen | $58 → $55 | Reiterates | → Buy | Get Alert |
| 04/04/2023 | Buy Now | 50% | Benchmark | Bruce Jackson | → $57 | Reiterates | → Buy | Get Alert |
| 04/04/2023 | Buy Now | 52.63% | HC Wainwright & Co. | Yi Chen | → $58 | Reiterates | → Buy | Get Alert |
| 02/22/2023 | Buy Now | 52.63% | HC Wainwright & Co. | Yi Chen | → $58 | Reiterates | → Buy | Get Alert |
| 02/21/2023 | Buy Now | 52.63% | HC Wainwright & Co. | Yi Chen | → $58 | Reiterates | → Buy | Get Alert |
| 08/01/2022 | Buy Now | 52.63% | HC Wainwright & Co. | Yi Chen | → $58 | Initiates | → Buy | Get Alert |
| 07/01/2022 | Buy Now | 50% | Benchmark | Bruce Jackson | → $57 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Belite Bio (BLTE)?
The latest price target for Belite Bio (NASDAQ: BLTE) was reported by Benchmark on May 16, 2024. The analyst firm set a price target for $57.00 expecting BLTE to rise to within 12 months (a possible 50.00% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Belite Bio (BLTE)?
The latest analyst rating for Belite Bio (NASDAQ: BLTE) was provided by Benchmark, and Belite Bio reiterated their buy rating.
When was the last upgrade for Belite Bio (BLTE)?
There is no last upgrade for Belite Bio.
When was the last downgrade for Belite Bio (BLTE)?
There is no last downgrade for Belite Bio.
When is the next analyst rating going to be posted or updated for Belite Bio (BLTE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Belite Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Belite Bio was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.
Is the Analyst Rating Belite Bio (BLTE) correct?
While ratings are subjective and will change, the latest Belite Bio (BLTE) rating was a reiterated with a price target of $0.00 to $57.00. The current price Belite Bio (BLTE) is trading at is $38.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.